Mode
Text Size
Log in / Sign up

CW-CPC shows greater sustained IOP reduction than MP-CPC in pediatric glaucoma meta-analysisReview finds continuous wave laser more effective than micropulse for childhood glaucoma pressure

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider CW-CPC for more sustained IOP reduction in pediatric glaucoma, but note high heterogeneity and absent safety data.

This systematic review and meta-analysis compared micropulse cyclophotocoagulation (MP-CPC) with continuous wave cyclophotocoagulation (CW-CPC) for intraocular pressure reduction in children with glaucoma. The analysis included comparative studies with a mean follow-up of 12.0 months, though the total sample size and specific study designs of included trials were not reported.

At 12 months, CW-CPC showed significantly greater IOP reduction than MP-CPC, with a mean difference of -6.88 mm Hg (95% CI: -9.46 to -4.30; P < 0.00001). At 1, 3, and 6 months, no significant differences in IOP lowering were observed between techniques. In the overall analysis of IOP reduction at last follow-up, CW-CPC remained superior with a mean difference of -4.23 mm Hg (95% CI: -6.51 to -1.95; P = 0.0003).

Key limitations include high statistical heterogeneity (I² = 80%) in the overall analysis, which suggests substantial variability between included studies. Safety outcomes, adverse events, tolerability, and discontinuation rates were not reported. The funding sources and potential conflicts of interest were also not reported.

For clinical practice, these findings suggest CW-CPC may provide more sustained IOP control in pediatric glaucoma compared with MP-CPC, particularly beyond 6 months. However, the absence of safety data and high heterogeneity limit definitive conclusions. Clinicians should consider these results alongside individual patient factors and the procedural risk profiles of each technique.

Researchers reviewed existing studies to compare two types of laser surgery for lowering eye pressure in children with glaucoma. They looked at a newer, gentler method called micropulse cyclophotocoagulation (MP-CPC) and an older, standard method called continuous wave cyclophotocoagulation (CW-CPC). The main goal was to see which was better at reducing intraocular pressure (IOP) over time.

The review found that the older, continuous wave laser was more effective at lowering eye pressure at the 12-month mark and at the final follow-up visit. The difference was considered significant. In the shorter term (1, 3, and 6 months), there was no clear difference in pressure reduction between the two methods.

It is important to be cautious about these results. The analysis showed high variability between the different studies that were combined, which makes the overall finding less certain. The review also did not report on the safety or side effects of either procedure. This means we don't know if one method caused more complications or was better tolerated by children. Readers should see this as an early signal from a review of past research, not a final answer on which treatment is best.

What this means for you:
A review suggests an older laser may lower eye pressure more in kids with glaucoma, but the evidence has limitations.

Study Details

Study typeMeta analysis
EvidenceLevel 1
Follow-up12.0 mo
PublishedApr 2026
View Original Abstract ↓
PRÉCIS: In this systematic review, we find that CW-CPC produces more sustained IOP lowering in children compared with MP-CPC. PURPOSE: Micropulse cyclophotocoagulation (MP-CPC) and continuous cyclophotocoagulation (CW-CPC) are both surgical interventions used to decrease intraocular pressure (IOP) in pediatric glaucoma. Recent publications have shown conflicting results regarding the effectiveness of MP-CPC compared with CW-CPC, which this systematic review and meta-analysis aims to evaluate. METHODS: From inception through March 2025, PubMed, Embase, Scopus, Cochrane Library, and ScienceDirect were searched for studies comparing MP-CPC and CW-CPC in treating pediatric glaucoma, with IOP reported at different time intervals. A random effects model was used across all analyses. RESULTS: At 12 months, CW-CPC showed a significantly greater reduction in IOP compared with MP-CPC (MD: -6.88 mm Hg, 95% CI: -9.46 to -4.30; P < 0.00001). No significant differences in IOP lowering were observed at 1, 3, and 6 months. Overall, CW-CPC was superior in reducing IOP (MD: -4.23 mm Hg, 95% CI: -6.51 to -1.95; P = 0.0003; I² = 80%) at the last follow-up. CONCLUSION: CW-CPC shows a significantly greater reduction in IOP than MP-CPC, particularly at long-term follow-up. These findings highlight the sustained efficacy of CW-CPC compared with MP-CPC in the management of pediatric glaucoma.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.